Tas Vildan, Birisci Esma, Jones Rachel Achor, Forbus John J, Blaszak Richard T, Crawford Brendan, Ilyas Mohammad, Magee James S, Sisterhen Laura L
From the Department of Pediatrics, University of Pittsburg Medical Center Children's Hospital of Pittsburgh, Little Rock, Penn.
Department of Econometrics, Bursa Uludağ University, Bursa, Turkey.
Pediatr Qual Saf. 2024 Jul 10;9(4):e746. doi: 10.1097/pq9.0000000000000746. eCollection 2024 Jul-Aug.
Adherence to the American Academy of Pediatrics clinical practice guidelines for screening and managing high blood pressure (BP) is low. This team sought to improve recognition and documentation of relevant diagnoses in patients aged 13-20 years who presented to general pediatric clinics.
The primary outcome measure was the proportion of office visits for patients ages 13-20 with a BP ≥ 120/80 with a visit or problem list diagnosis of hypertension or elevated BP. Secondary measures included (1) the proportion of patients who had their BP measured in the right arm, (2) the proportion of patients who had a mid-arm circumference measurement recorded, and (3) the proportion of patients who had a second BP reading measured at the visit. Interventions addressed key drivers for evidence-based high BP screening: standard BP measurement, electronic health record clinical decision support, and clinical pathway adoption. Data were collected over a twenty-seven-month period and plotted using the Laney p' chart.
Provider documentation of elevated BP or hypertension improved from a baseline mean of 24% in April 2020 through January 2022 to 41% in February 2021 through June 2022. All secondary outcome measures also demonstrated significant improvement.
This project demonstrates the feasibility of improving adherence to best practices of BP measurement in primary care clinics through education, acquisition of resources, and implementation of electronic health record flags for abnormal values.
美国儿科学会关于高血压筛查与管理的临床实践指南的依从性较低。该团队旨在提高到普通儿科诊所就诊的13至20岁患者相关诊断的识别与记录。
主要结局指标是13至20岁血压≥120/80且就诊记录或问题清单诊断为高血压或血压升高的患者的就诊比例。次要指标包括:(1)右臂测量血压的患者比例;(2)记录了上臂中部周长测量值的患者比例;(3)就诊时测量了第二次血压读数的患者比例。干预措施针对循证高血压筛查的关键驱动因素:标准血压测量、电子健康记录临床决策支持以及临床路径采用。数据在27个月期间收集,并使用莱尼p'图进行绘制。
2020年4月至2022年1月,血压升高或高血压的医疗服务提供者记录从基线平均值24%提高到2021年2月至2022年6月的41%。所有次要结局指标也都有显著改善。
该项目证明了通过教育、资源获取以及对异常值实施电子健康记录标记来提高基层医疗诊所血压测量最佳实践依从性的可行性。